Fig. 2: Difference analysis of gut microbiota between the two groups. | npj Precision Oncology

Fig. 2: Difference analysis of gut microbiota between the two groups.

From: Bifidobacterium boosts anti-PD-1 effectiveness through JAK pathway in hepatocellular carcinoma

Fig. 2

a LEfSe multilevel species level tree from the phylum to species level (LDA > 3). b LDA discrimination result table (LDA > 3). The differences in gut microbiota at the family level (c), and species level about Bifidobacterium. pseu (d) and Bifidobacterium. long (e). The date (d, e) were presented as mean ± s.d. n = 29 per group.

Back to article page